Initiativet Danmark som foregangsland på diabetesområdet blev præsenteret for en gruppe af vigtige "stakeholders" ved en reception på den danske ambassade i Washington DC. Programmet så således ud: Opening Peter Taksøe-Jensen, Denmark’s Ambassador to the United States Denmark on the Global Forefront in Diabetes Finn Stensbjerg Kristensen, CEO, JDRF Denmark Diabetes as a Competence Area, and the Importance of Competence Areas for Denmark Flemming Møller Mortensen, S, Sundhedsordfører/Parliament Health Spokesperson The Tradition and Status of Diabetes Research in Denmark Tore Christiansen, Managing Director, Danish Diabetes Academy John Bagterp Jørgensen, Associate Professor, DiaCon Commercial R&D and Diabetes Industry in Denmark Michael Mawby, Chief Government Affairs Officer, Novo Nordisk USA Adam Steensberg, Vice President, Head of Development, Zealand Pharma Henrik Egesborg, Managing Director, Medtronic R&D Treatment and Caregiving, Ambitions and Opportunities Martin Ridderstråle, Head of Clinic, Steno Diabetes Center Next Steps Liselott Blixt, DF, Sundhedsordfører/Parliament Health Spokesperson Q&A Host Peter Taksøe-Jensen, Denmark’s Ambassador to the United States, Embassy of Denmark in Washington DC Co-host Finn Stensbjerg Kristensen, CEO, JDRF Denmark Participants - Adam Steensberg, Vice President, Head of Development, Zealand Pharma - Flemming Møller Mortensen, Parliament Health Spokesperson - Griffin P. Rodgers, M.D., M.A.C.P., Director National Institute of Diabetes and Digestive and Kidney Diseases - Henrik Egesborg, Managing Director, Medtronic R&D - Ives, Ralph, Excecutive Vice President, AdvaMed - Joakim Steen Mikkelsen, Health Care Counselor, Embassy of Denmark in Washington DC - John Bagterp Jørgensen, Associate Professor, DiaCon - Leonard Pogach, MD, MBA, FACP National Director Medical Services/Diabetes and Endocrinology, VACO Office of Specialty Care/Office of Patient Care Services, U.S. Department of Veterans Affairs - Lina Gandløse Hansen, Commercial Counselor, Embassy of Denmark in Washington DC - Liselott Blixt, Parliament Health Spokesperson - Martin Ridderstråle, Head of Clinic, Steno Diabetes Center - Michael Mawby, Chief Government Affairs, Novo Nordisk, USA - Peter Bernstorff, International Policy Advisor, the Confederation of Danish Industry - Peter Cleary, Vice President for Communications, JDRF International, - Robert Ratner, Chief Medical Officer, American Diabetes Association - Tore Christiansen, Managing Director, Danish Diabetes Academy - Volney (Jim) Warner, Chief Learning Officer, U.S. Department of Veterans Affairs |
|
|